Insight in booster COVID-19 vaccine and disease modifying therapy in multiple sclerosis.

Beard, Katherine; Sriwastava, Shitiz

Beard, Katherine; Sriwastava, Shitiz.

Beard K; School of Medicine, West Virginia University, United States of America; Department of Neurology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States of America.
Sriwastava S; School of Medicine, West Virginia University, United States of America; Department of Neurology, Rockefeller Neuroscience Institute, West Virginia University, Morgantown, WV, United States of America; West Virginia Clinical and Translational Science Institute, United States of America. Electronic address: shitiz.sriwastava@hsc.wvu.edu.

J Neurol Sci ; 430: 120034, 2021 Nov 15.

Article in English | MEDLINE | ID: covidwho-1525858

Subject(s)

COVID-19; Multiple Sclerosis; COVID-19 Vaccines; Humans; Multiple Sclerosis/drug therapy; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Multiple Sclerosis Topics: Vaccines Limits: Humans Language: English Journal: J Neurol Sci Year: 2021 Document Type: Article Affiliation country: J.jns.2021.120034

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google